Product Overview: Synolis VA
Synolis VA 80mg is a cross-linked hyaluronic acid formulation developed by Aptissen for in-vitro research applications. This compound features modified hyaluronic acid chains designed for extended stability and controlled degradation profiles in laboratory settings. Researchers at Stroid UK Shop utilise this formulation to investigate viscoelastic properties, molecular interactions, and biomaterial compatibility across various experimental protocols.
The compound exhibits unique rheological characteristics that make it valuable for studying synovial fluid mechanics, cartilage matrix interactions, and tissue scaffold development. Its cross-linked structure provides enhanced resistance to enzymatic degradation compared to native hyaluronic acid, enabling extended observation periods in controlled laboratory environments. Research teams frequently examine this compound alongside other biomaterials available in our hyaluronic acid research collection for comparative analysis studies.
Laboratory Research Applications
Scientists investigate Synolis VA 80mg across multiple research domains including biomechanical testing, cellular interaction studies, and material science applications. The compound serves as an experimental substrate for evaluating chondrocyte behaviour, inflammatory response markers, and tissue regeneration pathways in controlled laboratory conditions. Researchers often combine these studies with investigations into selective androgen receptor modulators to examine tissue-selective effects on joint health markers.
Current research protocols examine the compound’s viscoelastic properties under varying temperature and pH conditions, providing insights into optimal storage and handling procedures for laboratory applications. Advanced studies explore its interaction with growth factors, cytokines, and other signalling molecules relevant to tissue engineering research. Many laboratories incorporate this compound into studies examining cellular proliferation, differentiation pathways, and extracellular matrix formation alongside research peptides for comprehensive biomaterial analysis.
Technical Specifications
| Parameter | Specification |
|---|---|
| Product Name | Synolis VA 80mg |
| Manufacturer | Aptissen |
| Active Component | Cross-linked Hyaluronic Acid |
| Concentration | 80mg per unit |
| Storage Requirements | 2-8°C, protect from light |
| Shelf Life | Verify with supplier documentation |
| Research Grade | Laboratory use only |
Research Compliance Statement
This product is manufactured and supplied exclusively for in-vitro research purposes by qualified laboratory personnel. Synolis VA 80mg is not intended for human or animal administration and must not be used for diagnostic or therapeutic applications. Researchers must follow appropriate laboratory safety protocols and institutional guidelines when handling this compound. All experimental work should be conducted within properly equipped laboratory facilities with adequate ventilation and safety measures. Documentation of research protocols and results should comply with relevant institutional review board requirements and laboratory record-keeping standards.
